NO20061424L - Fremgangsmote for fremstillingen av THIP - Google Patents

Fremgangsmote for fremstillingen av THIP

Info

Publication number
NO20061424L
NO20061424L NO20061424A NO20061424A NO20061424L NO 20061424 L NO20061424 L NO 20061424L NO 20061424 A NO20061424 A NO 20061424A NO 20061424 A NO20061424 A NO 20061424A NO 20061424 L NO20061424 L NO 20061424L
Authority
NO
Norway
Prior art keywords
thip
preparation
alkyl
acid
procedure
Prior art date
Application number
NO20061424A
Other languages
English (en)
Norwegian (no)
Inventor
Robert Dancer
Hans Petersen
Michael Bech Somrner
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=58707236&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20061424(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO20061424L publication Critical patent/NO20061424L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20061424A 2003-09-05 2006-03-29 Fremgangsmote for fremstillingen av THIP NO20061424L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50042203P 2003-09-05 2003-09-05
DKPA200301277 2003-09-05
PCT/DK2004/000579 WO2005023820A1 (en) 2003-09-05 2004-09-01 Method for the manufacture of thip

Publications (1)

Publication Number Publication Date
NO20061424L true NO20061424L (no) 2006-03-29

Family

ID=58707236

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20061424A NO20061424L (no) 2003-09-05 2006-03-29 Fremgangsmote for fremstillingen av THIP

Country Status (21)

Country Link
US (1) US7371863B2 (ja)
EP (1) EP1664060A1 (ja)
JP (1) JP4745233B2 (ja)
KR (1) KR20060069482A (ja)
CN (2) CN100482668C (ja)
AR (1) AR045540A1 (ja)
AU (1) AU2004270323B2 (ja)
BR (1) BRPI0413741A (ja)
CA (1) CA2537840C (ja)
EA (1) EA200600542A1 (ja)
HK (1) HK1096398A1 (ja)
IL (1) IL174070A (ja)
IS (1) IS8333A (ja)
ME (1) MEP1708A (ja)
MX (1) MXPA06002434A (ja)
NO (1) NO20061424L (ja)
NZ (1) NZ545178A (ja)
RS (1) RS20060157A (ja)
UA (1) UA91496C2 (ja)
WO (1) WO2005023820A1 (ja)
ZA (1) ZA200602178B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0402118D0 (en) 2004-01-30 2004-03-03 Merck Sharp & Dohme Polymorphic forms of a GABAA agonist
BRPI0509210A (pt) * 2004-04-02 2007-08-28 Lundbeck & Co As H uso de gaboxadol, e, métodos para tratar função respiratória enfraquecida, e apnéia do sono
CN104974175A (zh) * 2014-04-11 2015-10-14 天津药物研究院 一种氨甲基羟异恶唑类似物的制备方法
CN107428776B (zh) 2015-03-24 2020-10-23 H.隆德贝克有限公司 制造4,5,6,7-四氢异噁唑并[5,4-c]吡啶-3-醇
KR20210110585A (ko) 2018-11-21 2021-09-08 썰테고 테라퓨틱스 아이엔씨. 자살의 위험을 감소시키고 우울증의 신속한 완화를 위한 가복사돌
CN111320577B (zh) * 2018-12-13 2023-06-23 广东东阳光药业有限公司 一种吡啶酰胺的制备方法及其应用
CA3182508A1 (en) 2020-05-20 2021-11-25 Certego Therapeutics Inc. Ring deuterated gaboxadol and its use for the treatment of psychiatric disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK270378A (da) * 1977-06-20 1978-12-21 Krogsgaard Larsen P Isoxazolderivater
DE3145473A1 (de) 1980-11-27 1982-08-26 Kefalas A/S, Koebenhavn-Valby 2-substituierte 4,5,6,7-tetrahydroisoxazolo (5,4-c) pyridin-3-on-verbindungen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
GB2088370B (en) * 1980-11-27 1984-08-01 Kefalas As Tetrahydroisoxazolopyridine compounds
US4353910A (en) * 1981-11-27 1982-10-12 Kefalas A/S Derivatives of 4,5,6,7-tetrahydroisoxazolo [5,4-c] pyridine-3-one, pharmaceutical compositions and methods of treatment
DE19525598C2 (de) 1995-07-13 1997-09-25 Max Planck Gesellschaft Schlafmittel

Also Published As

Publication number Publication date
WO2005023820A1 (en) 2005-03-17
CN1845928A (zh) 2006-10-11
EP1664060A1 (en) 2006-06-07
JP4745233B2 (ja) 2011-08-10
MEP1708A (xx) 2010-02-10
BRPI0413741A (pt) 2006-10-24
MXPA06002434A (es) 2006-06-20
CN101497619A (zh) 2009-08-05
IL174070A (en) 2011-03-31
AR045540A1 (es) 2005-11-02
KR20060069482A (ko) 2006-06-21
RS20060157A (en) 2008-06-05
AU2004270323A1 (en) 2005-03-17
IL174070A0 (en) 2006-08-01
CA2537840C (en) 2011-10-25
US7371863B2 (en) 2008-05-13
UA91496C2 (en) 2010-08-10
ZA200602178B (en) 2007-07-25
HK1096398A1 (en) 2007-06-01
AU2004270323B2 (en) 2010-01-07
IS8333A (is) 2006-02-28
CA2537840A1 (en) 2005-03-17
CN100482668C (zh) 2009-04-29
JP2007504179A (ja) 2007-03-01
US20070112198A1 (en) 2007-05-17
EA200600542A1 (ru) 2006-08-25
NZ545178A (en) 2009-11-27

Similar Documents

Publication Publication Date Title
NO20061424L (no) Fremgangsmote for fremstillingen av THIP
NO20065830L (no) Substituerte 2-kinolyloksazoler som er anvendbare som PDE4-inhibitorer.
NO902214L (no) Fremgangsmaate for fremstilling av n-(aryloksyalkyl)-heteroarylpiperidiner og -heteroarylpiperaziner, deres fremstilling og anvendelse.
PE20051039A1 (es) [1,8] naftiridin-2-onas y compuestos relacionados
HRP20020175B1 (en) N-heterocyclikc derivatives as nos inhibitors
EA200501477A1 (ru) Производные пиперидинил- и пиперазинилалкилкарбаматов, способы их получения и применение их в терапии
MY142807A (en) Benzimidazole derivative and use thereof.
HRP20070430T3 (en) (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
DE602006008962D1 (de) Verfahren zur herstellung von valsartan
CA2324418A1 (en) Novel opiate compounds, methods of making and methods of use
PE20050480A1 (es) Acido [2-(8,9-dioxo-2,6-diazabiciclo [5.2.0] non-1(7)-en-2-il)alquil]fosfonico y derivados
NO20081056L (no) Nye, heterosykliske NF-kB-inhibitorer
PE20091887A1 (es) Fenoxibenzamidas sustituidas
NO20082226L (no) 6-heteroarylpyridoindolonderivater, deres fremstilling og terapeutisk anvendelse derav
AR023914A1 (es) Caprolactamas sustituidas, un proceso para su preparacion, composiciones farmaceuticas que las contienen, y su uso para la preparacion de composicionesfarmaceuticas en el tratamiento de tumores
GB0326964D0 (en) Chemical compounds
DE60335865D1 (de) Verfahren zur herstellung von cilostazol
NO330965B1 (no) Fremgangsmate for fremstilling av substituerte imidazolderivater, mellomprodukter anvendt i fremgangsmaten samt fremgangsmate for fremstilling av mellomprodukt
NO20073213L (no) Fremgangsmate for fremstilling av tiofenglykosidderivater
ATE524449T1 (de) Verfahren zur herstellung von cis-8b- methyldecahydro-2a,4a,6a,8a- tetraazacyclopentaäfgüacenaphthylen, cis- decahydro-2a,4a,6a,8a- tetraazacyclopentaäfgüacenaphthylen, cyclen und funktionalisierten cyclenen
BG106846A (en) Novel heteroaryl derivatives, their preparation and use
DE69107561D1 (de) Verfahren zur Herstellung von 4-Methylsulfonylbenzoesäurederivate und Zwischenprodukte.
NO20055755L (no) Nytt intermediat for fremstillingen av terapeutisk aktive imidazopyridiner
NO20002315D0 (no) Nye 1-aza-2-alkyl-6-aryl-cykloalkanforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem
SI2298754T1 (sl) Priprava derivatov taksana

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104

FC2A Withdrawal, rejection or dismissal of laid open patent application